3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Triple Negative Breast Neoplasms
5
Neoplasms
5
Breast Neoplasms
5
Recurrence
2
Ovarian Neoplasms
2
Hypersensitivity
2
Squamous Cell Lung Cancer
1
Solid Tumors
1
Neoplasm Metastasis
1
Glioblastoma
1
Fanconi Anemia, Complementation Group D1
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Female
1
Brain Neoplasms
1
Advanced Solid Tumors
1
Advance Solid Tumors
1
Interventions
iniparib
1
Gemcitabine
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Squamous Cell Lung Cancer
×
iniparib
×
Clear all
NCT01082549
2016-03-17
ECLIPSE
Sanofi
Phase 3
Completed
780 enrolled